Literature DB >> 5011105

Biologic activity of digoxin-specific antisera.

J F Watson, V P Butler.   

Abstract

Digoxin-specific antibodies are capable of removing essentially all intracellular digoxin from rat renal cortical slices or from human erythrocytes. In removing digoxin from erythrocytes, these antibodies are capable of reversing an effect of the drug on cellular potassium transport. This study provides direct evidence that antibodies are capable of removing, and thereby reversing the biological effect of, physiologically active low molecular weight substances after they have been taken up by mammalian cells. This biologic property of digoxin-specific antibodies suggests that autidigoxin sera may prove useful in the reversal of digoxin toxicity. Rapid and essentially quantitative removal of digoxin from red cells by antibody is not accompanied by an immediate restoration of patassium influx to normal levels. Identification of the mechanism of this phenomenon may provide useful information concerning the mode of action not only of digoxin, but also of the cation transport system of human erythrocytes.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 5011105      PMCID: PMC302170          DOI: 10.1172/JCI106853

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  29 in total

1.  ANTIBODIES SPECIFIC FOR RIBONUCLEOSIDES AND RIBONUCLEOTIDES AND THEIR REACTION WITH DNA.

Authors:  B F ERLANGER; S M BEISER
Journal:  Proc Natl Acad Sci U S A       Date:  1964-07       Impact factor: 11.205

2.  Purine-specific antibodies which react with deoxvribonucleic acid (DNA).

Authors:  V P BUTLER; S M BEISER; B F ERLANGER; S W TANENBAUM; S COHEN; A BENDICH
Journal:  Proc Natl Acad Sci U S A       Date:  1962-09-15       Impact factor: 11.205

3.  Extracellular space estimation in rat kidney slices using C saccharides and phlorizin.

Authors:  L E ROSENBERG; S J DOWNING; S SEGAL
Journal:  Am J Physiol       Date:  1962-04

4.  Digoxin-specific antibodies.

Authors:  V P Butler; J P Chen
Journal:  Proc Natl Acad Sci U S A       Date:  1967-01       Impact factor: 11.205

5.  Biologically effective immunization against angiotensin.

Authors:  D E Oken; T U Biber
Journal:  Am J Physiol       Date:  1968-04

6.  Antibody to lactate dehydrogenase. II. Uptake, accumulation and specific intracellular action in malignant cells.

Authors:  C W Ng; K F Gregory
Journal:  Biochim Biophys Acta       Date:  1968-11-12

7.  Antibodies to serotonin.

Authors:  N S Ranadive; A H Sehon
Journal:  Can J Biochem       Date:  1967-11

8.  Determination of therapeutic and toxic serum digoxin concentrations by radioimmunoassay.

Authors:  T W Smith; V P Butler; E Haber
Journal:  N Engl J Med       Date:  1969-11-27       Impact factor: 91.245

9.  The extracellular space in rat renal cortical slices incubated at 0.5 degrees and 25 degrees.

Authors:  A D Macknight
Journal:  Biochim Biophys Acta       Date:  1968-08

10.  Neutralization of airway effects on bradykinin by antibodies.

Authors:  T R Davis; T L Goodfriend
Journal:  Am J Physiol       Date:  1969-07
View more
  9 in total

1.  Monoclonal digoxin-specific antibodies induce dose- and affinity-dependent plasma digoxin redistribution in rats.

Authors:  N J Cano; A E Sabouraud; K Benmoussa; F Roquet; I Navarro-Teulon; J C Mani; J M Scherrmann
Journal:  Pharm Res       Date:  1995-05       Impact factor: 4.200

2.  Reversal of advanced digitoxin toxicity and modification of pharmacokinetics by specific antibodies and Fab fragments.

Authors:  H R Ochs; T W Smith
Journal:  J Clin Invest       Date:  1977-12       Impact factor: 14.808

3.  The influence of digoxin antibodies on digoxin disposition and effect: studies in guinea-pigs and HeLa cells.

Authors:  N M Griffiths; D S Hewick; J F Lamb; I H Stevenson
Journal:  Br J Pharmacol       Date:  1985-01       Impact factor: 8.739

4.  Effects of sheep digoxin-specific antibodies and their Fab fragments on digoxin pharmacokinetics in dogs.

Authors:  V P Butler; D H Schmidt; T W Smith; E Haber; B D Raynor; P Demartini
Journal:  J Clin Invest       Date:  1977-02       Impact factor: 14.808

5.  Effects of digoxin-specific antibodies on accumulation and binding of digoxin by human erythrocytes.

Authors:  J D Gardner; D R Kilno; T J Swartz; V P Butler
Journal:  J Clin Invest       Date:  1973-08       Impact factor: 14.808

6.  Effect of quinidine on the digoxin receptor in vitro.

Authors:  W J Ball; D Tse-Eng; E T Wallick; J P Bilezikian; A Schwartz; V P Butler
Journal:  J Clin Invest       Date:  1981-10       Impact factor: 14.808

Review 7.  Pharmacokinetic aspects of digoxin-specific Fab therapy in the management of digitalis toxicity.

Authors:  M R Ujhelyi; S Robert
Journal:  Clin Pharmacokinet       Date:  1995-06       Impact factor: 6.447

8.  Reversal of ouabain and acetyl strophanthidin effects in normal and failing cardiac muscle by specific antibody.

Authors:  H K Gold; T W Smith
Journal:  J Clin Invest       Date:  1974-06       Impact factor: 14.808

9.  Persistence of hapten-antibody complexes in the circulation of immunized animals after a single intravenous injection of hapten.

Authors:  D H Schmidt; B M Kaufman; V P Butler
Journal:  J Exp Med       Date:  1974-02-01       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.